Apoptosis of Hepatitis B Virus-expressing Liver Tumor Cells Induced by a High Concentration of Nucleos(t)ide Analogue

被引:3
|
作者
Tak, Eunyoung [1 ]
Hwang, Shin [2 ]
Lee, Han Chu [3 ]
Ko, Gi-Young [4 ]
Ahn, Chul-Soo [2 ]
Yoon, Young-In [2 ]
Lim, Young-Suk [3 ]
Jun, Dae-Young [1 ]
Kim, Ki-Hun [2 ]
Song, Gi-Won [2 ]
Moon, Deog-Bok [2 ]
Ryoo, Baek-Yeol [5 ]
Kim, Nayoung [1 ]
Lee, Sung-Gyu [2 ]
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg, 88 Olymp Ro 43 Gil, Seoul 138736, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol, Seoul, South Korea
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Diagnost Radiol, Seoul, South Korea
[5] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
Tenofovir; entecavir; covalently closed circular DNA; HBV X protein; transcatheter arterial chemoembolization; TENOFOVIR DISOPROXIL FUMARATE; CLOSED CIRCULAR DNA; HEPATOCELLULAR-CARCINOMA; IMMUNOGLOBULIN MONOTHERAPY; HBSAG SEROCLEARANCE; CLINICAL-OUTCOMES; RECURRENCE; THERAPY; RISK; TRANSPLANTATION;
D O I
10.21873/anticanres.11195
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background/Aim: We investigated the expression of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) and HBV X protein (HBx) in human hepatocellular carcinoma (HCC) and evaluated the effect of high-concentration nucleos(t)ide analogs (NUCs) on liver tumor cell lines. Materials and Methods: This study consisted of three parts: part I used human blood and non-tumor liver tissues; part II used human HCC and adjacent liver tissues; and part III used an HBV-expressing liver tumor cell line. Results: There were close correlations among blood and liver HBV DNA and liver cccDNA. HBV cccDNA and HBx were highly up-regulated in HCC compared to adjacent liver tissues despite NUC therapy. HBV cccDNA and HBx were highly up-regulated in the cccDNA-expressing HepG2.2.15 cell line. Their expression was down-regulated and apoptosis was induced by a very high concentration of NUCs in dose-and time-dependent manner. Conclusion: Very high concentrations of NUCs may have a novel potential to kill replicating HBV-expressing liver tumor cells.
引用
收藏
页码:6059 / 6069
页数:11
相关论文
共 50 条
  • [21] Persistence profile to nucleos(t)ide analogue treatment for patients with chronic hepatitis B
    Borrego Izquierdo, Yolanda
    Gomez Fernandez, Encarnacion
    Monje Agudo, Patricia
    Jimenez Galan, Rocio
    Almeida-Gonzalez, Carmen V.
    Ferrit Martin, Monica
    Morillo Verdugo, Ramon
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2016, 23 (05) : 278 - 282
  • [22] Longitudinal change of liver stiffness by transient elestography in chronic hepatitis B patients treated with nucleos(t)ide analogue
    Jang, Won
    Yu, Sung In
    Sinn, Dong Hyun
    Park, Sang Hoon
    Park, Hyun
    Park, Ji Young
    Jeon, Tae Joo
    Oh, Tae Hoon
    Shin, Won Chang
    Choi, Won-Choong
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2014, 38 (02) : 195 - 200
  • [23] Clonal expansion of hepatocytes and state of hepatitis B virus DNA integration in patients with nucleos(t)ide analogue therapy
    Chow, Ning
    Mak, Lung Yi
    Lai, Ching Lung
    Fung, Yan Yue James
    Seto, Wai-Kay
    Yuen, Man-Fung
    Wong, Danny Ka-Ho
    JOURNAL OF HEPATOLOGY, 2020, 73 : S602 - S603
  • [24] Hepatitis B Virus RNA as a Biomarker for Safe Antiviral Discontinuation: A Prospective Study of Nucleos(t)ide Analogue Withdrawal
    Terrault, Norah A.
    Sterling, Richard
    Lok, Anna S.
    Ghany, Marc G.
    Feld, Jordan J.
    Cloherty, Gavin
    Wahed, Abdus S.
    Yang, Xue
    Hepatitis B Res Network
    JOURNAL OF INFECTIOUS DISEASES, 2024,
  • [25] Chronic hepatitis B: a scoping review on the guidelines for stopping nucleos(t)ide analogue therapy
    Hui, Rex Wan-Hin
    Mak, Lung-Yi
    Seto, Wai-Kay
    Yuen, Man-Fung
    Fung, James
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2023, 17 (05) : 443 - 450
  • [26] Nucleos(t)ide analogue treatment reduces apoptotic activity in patients with chronic hepatitis B
    Farnik, Harald
    Lange, Christian Markus
    Hofmann, Wolf Peter
    Berger, Annemarie
    Allwinn, Regina
    Welker, Martin-Walter
    Trojan, Joerg
    Sarrazin, Christoph
    Herrmann, Eva
    Zeuzem, Stefan
    Kronenberger, Bernd
    JOURNAL OF CLINICAL VIROLOGY, 2011, 52 (03) : 204 - 209
  • [27] Association of nucleos(t)ide analogue therapy with Parkinson disease in chronic hepatitis B patients
    Jihye Lim
    Hyo Young Lee
    Hyunji Sang
    Su Jin Jeong
    Ha Il Kim
    Scientific Reports, 15 (1)
  • [28] Combination therapy with a nucleos(t)ide analogue and interferon for chronic hepatitis B: simultaneous or sequential
    Enomoto, Masaru
    Tamori, Akihiro
    Nishiguchi, Shuhei
    Kawada, Norifumi
    JOURNAL OF GASTROENTEROLOGY, 2013, 48 (09) : 999 - 1005
  • [29] Predictors for Efficacy of Combination Therapy with a Nucleos(t) ide Analogue and Interferon for Chronic Hepatitis B
    Li, Hong
    Wang, Hua
    Peng, Cheng
    Zheng, Xin
    Liu, Jia
    Weng, Zhi-hong
    Yang, Dong-liang
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2017, 37 (04) : 547 - 555
  • [30] Combination therapy with a nucleos(t)ide analogue and interferon for chronic hepatitis B: simultaneous or sequential
    Masaru Enomoto
    Akihiro Tamori
    Shuhei Nishiguchi
    Norifumi Kawada
    Journal of Gastroenterology, 2013, 48 : 999 - 1005